For Patients

​HUH Comprehensive Cancer Center performs a great deal of pharmaceutical research. Read on to find out how to participate in a clinical trial as a patient.

 

 

​Bladder cancer (1) Breast cancer (5) Cancer of the head and neck area (1) Colorectal cancer (2) GIST (3)   Lymphoma (4)   Melanoma (1) Prostate cancer (1) Solid tumor (7)

​Hematological cancer ALL - Acute lymphoblastic leukemia (1) AML - Acute myeloid leukemia (4) CLL - Chronic lymphoid leukemia (1) CML - Chronic myeloid leukemia (1) MDS - Myelodysplastic syndrome (1) Myeloma (1)

 

You can be referred to a clinical trial by your physician. You can also contact the clinical trial unit’s nurse manager directly and they can give you information on how to become a clinical trial participant, and help with finding a suitable trial if one is available.

tel. +358 50 427 0680

 

All clinical trial participants are required to meet the trial’s inclusion criteria. The inclusion criteria vary from trial to trial, and they are defined in detail in each research agenda. The patients are required to follow the instructions they receive from the clinical trial’s physician/nurse.

If it appears that you may be eligible for a clinical trial currently underway in HUH Comprehensive Cancer Center after you have contacted us, you will be asked to sign the information leaflet and consent document for the trial in question.

After this, you will undergo more detailed examinations in the Cancer Center regarding your eligibility for this clinical trial. These examinations usually include laboratory tests and X-ray imaging. Both the eligibility examinations and participation in a clinical trial are free of charge for the patient. Patients can participate in HUH Comprehensive Cancer Center clinical trials regardless of their municipality of residence.

 

Participation in clinical trials is always voluntary. You may cancel your consent to participate in a trial at any point without any disadvantages caused by the cancellation.

 

All clinical trials performed in HUH Comprehensive Cancer Center have been approved by the Ethics Committee. Additionally, clinical trials are approved by the supervisory authority (FIMEA).